Shenogen Pharma Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Shenogen Pharma Group Ltd (Shenogen) is a drug discovery and development company that develops therapeutics for cancer treatment. The company develops biologic drugs and small molecule targeted at the new estrogen receptor variant. It provides SNG-162 that is a small molecule naturally derived a TCM. Shenogen is also developing second generation small molecule SNG-1153, which is ready for investigational new drug application. Shenogen offers other pipeline products such as SNG-8023 and companion diagnostic kit. The company provides solutions used in treatment of breast cancer, leukemia, prostate cancer and osteoporosis. Shenogen is headquartered in Beijing, China.

Shenogen Pharma Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Shenogen Pharma Raises US$20 Million In Series C Financing 10
Partnerships 12
Lees Pharma Enters into Agreement with Shenogen Pharma 12
Equity Offering 13
Shenogen Pharma May Raise USD300 Million in IPO 13
Shenogen PharmaGroup Ltd - Key Competitors 14
Shenogen PharmaGroup Ltd - Key Employees 15
Shenogen PharmaGroup Ltd - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Feb 06, 2018: The Team of Prof. Xiuwu Bian, Academician of the Chinese Academy of Sciences Found Targeting ER36 Potential To Be Novel Therapy for Tamoxifen-Resistant Breast Cancer 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shenogen PharmaGroup Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shenogen Pharma Raises US$20 Million In Series C Financing 10
Lees Pharma Enters into Agreement with Shenogen Pharma 12
Shenogen Pharma May Raise USD300 Million in IPO 13
Shenogen PharmaGroup Ltd, Key Competitors 14
Shenogen PharmaGroup Ltd, Key Employees 15

List Of Figures


Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shenogen PharmaGroup Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Shenogen Pharma Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Shenogen Pharma Group Ltd (Shenogen) is a drug discovery and development company that develops therapeutics for cancer treatment. The company develops biologic drugs and small molecule targeted at the new

USD 250 View Report

Tanner Pharma Group Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tanner Pharma Group Inc (Tanner Pharma), a subsidiary of Bourne Capital Partners LLC, is a pharmaceutical services company which offers distribution, licensing and commercialization of health care products. The company

USD 250 View Report

Luye Pharma Group Co Ltd (2186) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system.

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available